Cannasouth confirms GMP Audit Date for Cultivation Facility

Cannasouth Ltd (NZX:CBD) (the Company) confirms the GMP audit of its cultivation and post-harvest facility by Medsafe is scheduled for the 27-29th March 2023. Good Manufacturing Practices (GMP) covers the post-harvest, drying and packing processes. This is important because for higher value premium flower to be used as a finished product requires GMP certification for certain post-harvest activities in most jurisdictions, including New Zealand. All flower produced already has a Good Agricultural and Collection Practice (GACP) certification, which covers the propagation and cultivation activities. GACP was achieved in 2022 and is required by many countries for the import of bulk cannabis flower to be used as a start material for further processing. CEO Mark Lucas says, "Cannasouth's cultivation and post-harvest facility is one of only a few of its type that has been specifically designed to operate with these two quality standards. "We are pleased with the preparation we have made for the audit, and our new Chief Compliance Officer, Pierre Booysen, is proving a valuable member of the team." Once GMP certification is achieved Cannasouth will submit product assessment applications for premium dried flower as a finished product to enable sales of New Zealand-grown flower products to New Zealand patients, and for export. Completion of Cannasouth's proposed merger with Eqalis, announced on 19 December 2022, will result in an end-to-end GMP capable business operation with diversified product offerings for New Zealand patients and export customers. -ENDS- For further information visit www.cannasouth.co.nz or contact: Mark Lucas CEO / Executive Director Email: mark.lucas@cannasouth.co.nz Mobile: 021 484 649 Colin Foster CFO / Company Secretary Email: colin.foster@cannasouth.co.nz Mobile: 027 577 1498 End CA:00407251 For:CBD Type:MKTUPDTE Time:2023-02-23 15:54:16